Home » Topics » BioWorld

BioWorld
RSS

BIOTECHNICA LICENSES MGI's CORN GENE

Aug. 21, 1991

APPLIED IMAGING BUYS DIVISION OF BRITISH FIRM

Aug. 21, 1991

VIMRX SHIPS AIDS TREATMENT TO NIH

Aug. 21, 1991

COLUMBIA RAISES $15 MILLION

Aug. 21, 1991

PERSEPTIVE RAISES $6.75M IN FUNDING

Aug. 21, 1991

FIVE MORE SUITS FILED AGAINST XOMA

Aug. 21, 1991

COLLAGEN COMPLIES WITH LABELING CHANGES

Aug. 21, 1991

TWO COMPANIES TEST IPO MARKET

Aug. 21, 1991

AMGEN SELLS REAGENT, DIAGNOSTIC BUSINESSES

Aug. 21, 1991

INTERNEURON DEAL FOR ALZHEIMER'S DRUG

Aug. 20, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...